Char syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Char syndrome | |
|---|---|
| Error creating thumbnail: | |
| Synonyms | Patent ductus arteriosus with facial dysmorphism and hand anomalies |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Facial dysmorphism, patent ductus arteriosus, hand anomalies |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the TFAP2B gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Other syndromes with similar features |
| Prevention | Genetic counseling |
| Treatment | Symptomatic treatment, surgical correction of heart defects |
| Medication | |
| Prognosis | Variable, depending on severity of symptoms |
| Frequency | Rare |
| Deaths | N/A |
Other Names:
CHAR; Patent ductus arteriosus with facial dysmorphism and abnormal fifth digits
Char syndrome is a condition that affects the development of the face, heart, and limbs.
It is characterized by a combination of three major features: a distinctive facial appearance, a heart defect called patent ductus arteriosus, and hand abnormalities.
Genetics[edit]
Char syndrome is caused by mutations in the TFAP2B gene and is inherited in an autosomal dominant fashion. During embryo development, TFAP2B regulates the production of the protein AP-2β, a transcription factor that is active in the neural crest and helps regulate genes that control cell division and apoptosis. There are at least 10 mutations of this gene that has been identified in people presenting Char syndrome, which alters specific regions of the gene preventing production of the transcription factor and disrupting normal development of embryo structures.
Symptoms[edit]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
- Depressed nasal bridge(Depressed bridge of nose)
- Depressed nasal ridge(Flat nose)
- Downslanted palpebral fissures(Downward slanting of the opening between the eyelids)
- Everted lower lip vermilion(Drooping lower lip)
- Hypertelorism(Wide-set eyes)
- Malar flattening(Zygomatic flattening)
- Patent ductus arteriosus
- Ptosis(Drooping upper eyelid)
- Short philtrum
- Thick vermilion borde(Full lips)
- Triangular mouth(Triangular shaped mouth)
30%-79% of people have these symptoms
- Clinodactyly of the 5th finger(Permanent curving of the pinkie finger)
- Mesoaxial hand polydactyly
- Short middle phalanx of the 5th finger(Short middle bone of the little finger)
5%-29% of people have these symptoms
- Global developmental delay
- Hearing impairment(Deafness)
- Mesoaxial foot polydactyly(Central polydactyly of feet)
- Myopia(Close sighted)
- No permanent dentition(Absence of adult teeth)
- Persistence of primary teeth(Delayed loss of baby teeth)
- Prominent occiput(Prominent back of the skull)
- Sleep disturbance(Difficulty sleeping)
- Strabismus(Cross-eyed)
- Supernumerary nipple(Accessory nipple)
- Symphalangism of the 5th finger(Fused little finger bones)
- Toe syndactyly(Fused toes)
- Ventricular septal defect(Hole in heart wall separating two lower heart chambers)
Diagnosis[edit]
Making a diagnosis for a genetic or rare disease can often be challenging. The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.
Treatment[edit]
The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition. Ibuprofen lysine (Brand name: NeoProfen®)For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g,
who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc)
NIH genetic and rare disease info[edit]
Char syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Char syndrome
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian